Today, Explained A cancer vaccine?
17 snips
May 24, 2023 In this engaging discussion, science journalist Charles Graeber highlights groundbreaking work in cancer treatment, including the innovative use of personalized mRNA vaccines for pancreatic cancer. He likens this moment to cancer's 'penicillin moment,' marking a dramatic shift in how we view and treat the disease. The conversation dives into the promise of immunotherapy, the complexities of development, and how these advances could lead to managing cancer as a chronic condition. Hope for the future of cancer treatment shines through!
AI Snips
Chapters
Books
Transcript
Episode notes
Studying Long-Term Survivors
- Researchers studied long-term pancreatic cancer survivors.
- They aimed to understand how these survivors' immune systems recognize and fight cancer.
T-Cells and Personalized Vaccines
- T-cells recognize and kill cells with foreign proteins.
- These proteins are individual to every patient's tumor, requiring personalized vaccines.
BioNTech Partnership
- The clinical trial started in 2017.
- It partnered with BioNTech, then a small, lesser-known German company specializing in mRNA technology.
